
    
      The study was a randomized double-blind sham-controlled trial for 4 weeks. Patients with
      schizophrenia were treated with 20-Hz rTMS for 4 weeks to the left dorsolateral prefrontal
      cortex (added to the ongoing treatment). Negative symptoms were assessed with the Scale for
      the Assessment of Negative Symptoms (SANS), the Positive and Negative symptom scale
      (PANSS).The auditory steady state responses (ASSR) were obtained for the assessment of gamma
      oscillation.And cognitive symptoms were assessed by MATRICS cognitive test battery (MCCB)
      Chinese version and n-back task.
    
  